✦ LIBER ✦

Expression of epidermal growth factor receptor 1 (EGFR1) is correlated with over-expression of c-erbB-2, and higher expression of the angiogenic factors basic fibroblast growth factor (BFGF) and vascular endothelial growth factor (VEGF), but do not add prognostic information in primary breast cancer

✍ Scribed by B.K. Linderholm; B. Lindh; B. Tavelin; M. Erlanson; L. Beckman; K. Grankvist; R. Henriksson

Book ID: 114315597
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 196 KB
Volume: 12
Category: Article
ISSN: 0960-9776
DOI: 10.1016/s0960-9776(03)80072-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Overexpression of c-erbB-2 is related to

Overexpression of c-erbB-2 is related to a higher expression of vascular endothelial growth factor (VEGF) and constitutes an independent prognostic factor in primary node-positive breast cancer after adjuvant systemic treatment

✍ B. Linderholm; J. Andersson; B. Lindh; L. Beckman; M. Erlanson; K. Edin; B. Tave 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 249 KB

Human epidermal growth factor receptor 1

Human epidermal growth factor receptor 1 (EGFR) expression was not associated with gene amplification but intimately assoclated with HER2 gene amplification and protein expression in tissue microarray of clinical breast cancers

✍ S.K. Ahn; Gwak; K. Park; J. Kim; H. Park; S. Han; S.K. Ahn 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 275 KB

Prognostic significance of the expressio

Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer

✍ Enrique Carrillo de Santa Pau; Fernando Carrillo Arias; Enrique Caso Peláez; Gem 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 779 KB

## Abstract ## BACKGROUND: Lung cancer is the leading cause of cancer death in the world. The objective of this study was to investigate the expression of vascular endothelial growth factors (VEGFs) and their receptors (VEGFRs) in patients with nonsmall cell lung cancer (NSCLC) and its correlation